NCT02771977View on ClinicalTrials.gov

Drug-Targeted Alerts for Acute Kidney Injury

NACompletedINTERVENTIONAL
Enrollment

5,060

Participants

Timeline

Start Date

August 24, 2020

Primary Completion Date

December 20, 2021

Study Completion Date

January 4, 2022

Conditions
Acute Kidney Injury
Interventions
OTHER

Drug-specific alert

A drug-specific alert, informing the provider of the presence of AKI as well as recent exposure to a potentially nephrotoxic agent, will be fired.

Trial Locations (1)

06510

Yale New Haven Hospital, New Haven

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Yale University

OTHER

NCT02771977 - Drug-Targeted Alerts for Acute Kidney Injury | Biotech Hunter | Biotech Hunter